Back

Anticoagulation can be stopped after successful catheter ablation of AF in patients with CHADSVASC ≥2 risk of thromboembolism- PRO

18 March 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Tough decisions in anticoagulation in atrial fibrillation Stroke Prevention in Cardioversion EHRA Premium Access EHRA 2018

About the speaker

Photo
Doctor Sakis Themistoclakis

Hospital of the Angelo Mestre, Venice (Italy)

11 More presentations in this session

Presentation thumbnail
Opening question
Slides Video
Presentation thumbnail
Anticoagulation can be stopped after successful catheter ablation of AF in patients with CHADSVASC ≥2 risk of thromboembolism - CON
Professor T. Potpara (Belgrade, RS)
Slides Video
Presentation thumbnail
Anticoagulation can be stopped after successful catheter ablation of AF in patients with CHADSVASC ≥2 risk of thromboembolism - Rebuttal PRO
Video
Presentation thumbnail
Anticoagulation can be stopped after successful catheter ablation of AF in patients with CHADSVASC ≥2 risk of thromboembolism - Rebuttal CON
Video
Presentation thumbnail
Chairperson conclusion & Closing question
Slides Video

Access the full session

Session thumbnail
Tough decisions in anticoagulation in atrial fibrillation

The Event

Event poster

EHRA 2018

18 March - 20 March 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources